Synergistic malaria vaccine combinations identified by systematic antigen screening

scientific article

Synergistic malaria vaccine combinations identified by systematic antigen screening is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1073/PNAS.1702944114
P932PMC publication ID5692528
P698PubMed publication ID29078270

P50authorOgobara K. DoumboQ3349810
Julian RaynerQ22278468
Pietro CicutaQ41600942
Tuan M TranQ50285663
Gareth T. PowellQ55294206
Gavin J. WrightQ55838269
Theo SandersonQ56368622
Boubacar TraoreQ62672878
Peter D CromptonQ91078865
Cecile CrosnierQ91288456
Leyla Y BustamanteQ125171041
P2093author name stringYen-Chun Lin
Alison Kemp
Michael D Macklin
Nadia Cross
Nicole Muller-Sienerth
Paula Cawkill
P2860cites workSpread of artemisinin resistance in Plasmodium falciparum malariaQ21032481
Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparumQ24297064
High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cellsQ24548319
Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line systemQ26700012
Paths to a malaria vaccine illuminated by parasite genomicsQ26853267
Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidateQ27230019
Multiprotein complex between the GPI-anchored CyRPA with PfRH5 and PfRipr is crucial for Plasmodium falciparum erythrocyte invasionQ27230042
Revealing the sequence and resulting cellular morphology of receptor-ligand interactions during Plasmodium falciparum invasion of erythrocytesQ27321307
Biochemical analysis of the Plasmodium falciparum erythrocyte-binding antigen-175 (EBA175)-glycophorin-A interaction: implications for vaccine designQ27973510
A subset of Plasmodium falciparum SERA genes are expressed and appear to play an important role in the erythrocytic cycleQ27974188
The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015Q28267425
A phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide® ISA 720Q28744696
Deletion of the Plasmodium falciparum merozoite surface protein 7 gene impairs parasite invasion of erythrocytesQ30042482
Transcriptional profiling of growth perturbations of the human malaria parasite Plasmodium falciparumQ30044443
Passive immunoprotection of Plasmodium falciparum-infected mice designates the CyRPA as candidate malaria vaccine antigenQ30049113
Essential Role of the PfRh5/PfRipr/CyRPA Complex during Plasmodium falciparum Invasion of ErythrocytesQ30049125
Genomic epidemiology of artemisinin resistant malariaQ31075546
Antibodies to rhoptry-associated membrane antigen predict resistance to Plasmodium falciparumQ33221359
Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western KenyaQ33415066
An adaptable two-color flow cytometric assay to quantitate the invasion of erythrocytes by Plasmodium falciparum parasitesQ33703948
A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarrayQ33859633
Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malariaQ33925720
Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trialQ34043843
The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibodyQ34241973
An expanding ebl family of Plasmodium falciparumQ34264741
An automated live imaging platform for studying merozoite egress-invasion in malaria culturesQ34615281
A library of functional recombinant cell-surface and secreted P. falciparum merozoite proteinsQ34991300
New antigens for a multicomponent blood-stage malaria vaccineQ35216634
Basigin is a druggable target for host-oriented antimalarial interventionsQ35894355
Antimalarial drug synergism and antagonism: mechanistic and clinical significance.Q36294193
A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variantsQ36511421
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria VaccineQ36603519
Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malariaQ37582331
Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparumQ37598726
A genome-wide map of diversity in Plasmodium falciparumQ44045368
Kinetic constraints on the development of a malaria vaccineQ47887346
P433issue45
P407language of work or nameEnglishQ1860
P921main subjectmalariaQ12156
malaria vaccineQ6741353
P304page(s)12045-12050
P577publication date2017-10-23
P1433published inProceedings of the National Academy of Sciences of the United States of AmericaQ1146531
P1476titleSynergistic malaria vaccine combinations identified by systematic antigen screening
P478volume114

Reverse relations

cites work (P2860)
Q58118436A library of recombinant Babesia microti cell surface and secreted proteins for diagnostics discovery and reverse vaccinology
Q57295570A plug-and-play approach for malaria vaccination
Q93064802Adaptive NK cells in people exposed to Plasmodium falciparum correlate with protection from malaria
Q92095524Antibodies against a short region of PfRipr inhibit Plasmodium falciparum merozoite invasion and PfRipr interaction with Rh5 and SEMA7A
Q97548491Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations
Q92058833Constituting a glutathione S-transferase-cocktail vaccine against tick infestation
Q92993772Erythrocyte glycophorins as receptors for Plasmodium merozoites
Q64967277Functional Comparison of Blood-Stage Plasmodium falciparum Malaria Vaccine Candidate Antigens.
Q92781089Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies
Q56383949Malaria
Q56362064Malaria Vaccines: Recent Advances and New Horizons
Q94602401Malaria vaccines: facing unknowns
Q92972427Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes
Q89559300Vaccination with virosomally formulated recombinant CyRPA elicits protective antibodies against Plasmodium falciparum parasites in preclinical in vitro and in vivo models

Search more.